Literature DB >> 6093785

Distinct receptors for IGF-I, IGF-II, and insulin are present on bovine capillary endothelial cells and large vessel endothelial cells.

R S Bar, M Boes.   

Abstract

Endothelial cells were cultured from bovine fat capillaries, aortae and pulmonary arteries and their interactions with 125I-IGF-I, 125I-MSA (an IGF-II), 125I-insulin and the corresponding unlabeled hormones were evaluated. Each endothelial culture showed similar binding parameters. With 125I-insulin, unlabeled insulin competed with high affinity while IGF-I and MSA were approximately 1% as potent. With 125I-MSA, MSA was greater than or equal to IGF-I in potency and insulin did not compete for binding. Using 125I-IGF-I, IGF-I was greater than or equal to MSA whereas insulin decreased 125I-IGF-I binding by up to 72%. Exposing cells to anti-insulin receptor antibodies inhibited 125I-insulin binding by greater than 90%, did not change 125I-MSA binding, while 125I-IGF-I binding was decreased by 30-44%, suggesting overlapping antigenic determinants between IGF-I and insulin receptors that were not present on MSA receptors. We conclude that cultured capillary and large vessel endothelial cells have distinct receptors for insulin, IGF-I and MSA (IGF-II).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6093785     DOI: 10.1016/0006-291x(84)90937-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Enhancing engineered vascular networks in vitro and in vivo: The effects of IGF1 on vascular development and durability.

Authors:  Claudia C Friedrich; Yunfeng Lin; Alexander Krannich; Yinan Wu; Joseph P Vacanti; Craig M Neville
Journal:  Cell Prolif       Date:  2017-11-07       Impact factor: 6.831

2.  Metabolic response of sheep skin to a chronic infusion of a variant of insulin-like growth factor I.

Authors:  J E Hocking Edwards; S K Khalaf; B R Sinclaire; J Lee; C G Prosser; P M Harris
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

3.  Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo.

Authors:  Meit Björndahl; Renhai Cao; L Johan Nissen; Steve Clasper; Louise A Johnson; Yuan Xue; Zhongjun Zhou; David Jackson; Anker Jon Hansen; Yihai Cao
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

4.  Insulin-like growth factor-1 as a prognostic marker in patients with acute ischemic stroke.

Authors:  Jian-Hua Tang; Li-Li Ma; Tian-Xia Yu; Juan Zheng; Hui-Juan Zhang; Hui Liang; Peng Shao
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.